Skip to content
Open access · CC-BY via OpenAlex

Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease

Baruh Polis, Abraham O. Samson

Neural Regeneration Research · 2020 · ▲ 17 citations

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, eventually manifesting in severe cognitive dysfunction. Despite the recent proliferation of encouraging preclinical studies and clinical trials, scientific society is still far from a complete consensus regarding the AD etiology and pathogenesis. Accordingly, no approved AD-modifying therapies are currently available. Nevertheless, novel concepts predicated upon the latest discoveries and comprehension of the disease as a multifactorial disorder are paving the road to the successful AD treatment. Accruing evidence indicates the role of systemic and brain metabolic aberrations, in addition to the canonical hallmarks, in AD pathogenesis (Polis and Samson, 2019). The up-to-date description of AD-associated pathology includes neuroinflammation, mitochondrial dysfunction(definition), instigated apoptosis, and chronic oxidative stress. Of note, oxidative damage is one of the earliest events causing and following AD (Nunomura et al., 2001). Moreover, oxidative damage is strongly associated with neurodegenerative processes and it is a connecting factor between β-amyloidosis, τ-protein hyperphosphorylation, and neuronal loss. Oxidative stress due to the disbalance between generation and elimination of reactive oxygen species (ROS) plays a key role in β-amyloid-mediated cytotoxicity via a spectrum of molecular events that eventually lead to a substantial neuronal loss, which is a primary hallmark of AD, clinically manifesting in cognitive decline. In healthy individuals, excessive ROS production is counteracted by physiological antioxidant mechanisms that incessantly maintain redox homeostasis. However, these mechanisms are inadequate in the AD brain tissue and do not provide the necessary protection against highly reactive species, which disrupt membrane function, impair enzymes, break polysaccharides, and damage nucleic acids. It is worth noting that oxidative stress characterizes normal aging as well, and leads to protein aggregation and misfolding in the brain. The hypothesis concerning the role of ROS and age-related changes in the pro-oxidant brain status, that contribute to the AD pathogenesis, was articulated long ago (Benzi and Moretti, 1995). This theory considers the extreme sensitivity of the brain to oxidative damage, due to its enormous metabolic rate together with a relatively large content of catecholamines and unsaturated lipids, as a prompting neurodegeneration factor. Recent translational studies prove the involvement of ROS in AD-associated pathology and open new treatment avenues. Continuous life-long neuronal loss was supposed to be irreversible and cause, in some cases, cognitive impairment and neurological diseases. The brain capability to generate new neurons was confined to a distinct developmental period. However, murine and human studies have demonstrated the persistence of adult neurogenesis throughout life in several brain areas. Even though neurogenesis gradually wanes in aging animals and men, strong evidence verifies the presence of newborn cells in the brains of centenarians and AD patients (Tobin et al., 2019). Nevertheless, the density of neuronal progenitors is substantially decreased in cases of clinical AD in comparison with healthy age-matched controls, indicating severe impairment of this natural brain self-repair mechanism in AD (Moreno-Jiménez et al., 2019). Of note, some human-based postmortem studies report a significant increase in the levels of neurogenesis-related markers in AD patients compared to healthy controls (Jin et al., 2004), which is the stage-dependent phenomenon reflecting the compensatory effect to emerging neurodegeneration. However, advanced AD pathology is characterized by a decrease in the rate of neuronal replacement in the hippocampus, pointing to an imbalance between neurogenesis and neurodegeneration in this pathology. Adult neurogenesis is an intricate multistage process including the proliferation of neural progenitors, migration of newborn cells, and their differentiation into a distinct neuronal phenotype following by functional integration into specific circuits. The newborn neuronal cells originate from neural stem cells of the definite germinal zones and are characterized by self-replication ability and differentiation into several lineages, including neurons and glia. Neuronal precursors have been identified in various adult brain regions; however, active neurogenesis is localized in the subventricular zone and the hippocampal dentate gyrus, both of which unremittingly generate neurons during adulthood and even senescence(definition). This capability, as a form of neural plasticity, seems to be evolutionary significant for species living in a continually changing environment, providing mammalian brains with a superb capacity to cope with extreme cognitive and emotional challenges. Accordingly, adult neurogenesis is controlled by plenteous behavior-associated factors. Empirical evidence demonstrating the experience-dependent differentiation and functional integration of newborn neurons, proves the neurogenesis contributing role in learning and memory acquisition mechanisms (Deng et al., 2010). Environmental enrichment and physical exercise escalate the rate of neurogenesis in rodents. Voluntary running, in mice, and intense walking in men, have been shown to support neurogenesis in normal aging and halt the AD-related cognitive decline. Aerobic exercise, in particular, modulates the redox brain status and improves the resistance against oxidative stress attenuating the age-associated cognitive decline and the manifestation of AD. Conversely, an artificial extension of the adult-born neurons population in mice improves specific cognitive performances. Moreover, the instigation of adult neurogenesis combined with training upturn exploratory behavior (Sahay et al., 2011). Therefore, therapeutic strategies for manipulating neurogenesis by decreasing the rate of cell death and by in

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4103/1673-5374.293138
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Polis, B., &amp; Samson, A.O. (2020). Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease. <em>Neural Regeneration Research</em>. https://doi.org/10.4103/1673-5374.293138
Vancouver
Polis B, Samson AO. Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease. Neural Regeneration Research. 2020. doi:10.4103/1673-5374.293138.
BibTeX
@article{baruh2020Neurog, title = {Neurogenesis versus neurodegeneration: the broken balance in Alzheimer’s disease}, author = {Baruh Polis and Abraham O. Samson}, journal = {Neural Regeneration Research}, year = {2020}, doi = {10.4103/1673-5374.293138}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings